Scroll To Top

HIV Can Rebound in Nursing Mothers

HIV Can Rebound in Nursing Mothers


A short course of AZT can help prevent mother-to-child HIV transmissions, but stopping the medication can cause a temporary burst in viral replication in breast milk that can expose nursing babies to higher risks of HIV infection, according to a study in the October 15 edition of Journal of Infectious Diseases. Investigators examined HIV RNA levels in the breastmilk of both HIV-positive women who did and who did not take AZT at eight-, 45-, 90-, and 180-day follow-up evaluations after delivery. AZT therapy was stopped at the seven-day point after delivery for women in the treatment arm of the study. HIV was detected in the breast milk of about 33% of the women who took AZT and 55% of those who did not take the drug at the eight-day postdelivery mark. Among those women who had taken AZT and did have measurable viral levels, their viral loads still were significantly lower than the levels in women who received a placebo. However, by the 45-day follow-up point, viral levels among both treated and untreated women were similar, indicating that there is a burst of viral replication between the eight- and 45-day postdelivery period in women who had taken a short course of AZT. Based on these findings, the researchers recommend that 'AZT should be provided to nursing mothers for the duration of breast feeding.'

Out Subscription Lil Nas XAdvocateChannel promotion

From our Sponsors

Most Popular

Fifth Person Cured of HIV

Latest Stories